MedPath

Testing the Effectiveness of an Online Behavioral Intervention in Reducing Loneliness

Not Applicable
Completed
Conditions
Loneliness
Psychological Distress
Registration Number
NCT04112225
Lead Sponsor
Happify Inc.
Brief Summary

This study will use a longitudinal randomized experimental design. Participants will be randomly assigned to either a positive affect skills intervention or a psychoeducation control group and assessed with questionnaires at baseline and immediately post 8-week intervention.

Detailed Description

Participants will be randomly assigned to either a positive affect skills intervention or a psychoeducation control group, with each intervention lasting 8-weeks. Participants in the positive affect skills intervention will have full access to the unchanged Happify platform.

The psychoeducation control group participants will use a version of the Happify platform that encourages thinking about well-being through quizzes and polls without providing any instructions for promotion (i.e., Wait-list Control). Participants will be asked to complete questionnaires before and after the 8-week program, at which point study participation will end.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
890
Inclusion Criteria
  • No prior experience on the Happify platform (new user registration)
  • Located in the United States
  • Self reported loneliness/desire to be more connected to others
Exclusion Criteria
  • Participants who are under the age of 18, reside outside of the United States, have previously registered for Happify, or did not self report loneliness/desire to be more connected with others

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Loneliness (Revised UCLA Loneliness Scale; Russell, Peplau, & Cutrona, 1980)From start of 8-week intervention (baseline) to immediately post-intervention

A 20-item scale designed to measure one's subjective feelings of loneliness as well as feelings of social isolation.

Secondary Outcome Measures
NameTimeMethod
Resilience(composite of Perceived Stress Scale [Cohen et al., 1983], Happify Scale [Carpenter et al., 2016] and Life Orientation Scale, Revised [Scheier & Carver, 1985])From start of 8-week intervention (baseline) to immediately post-intervention

Composite score made of perceived stress, positive emotionality, and optimism. Perceived stress was measured using the Perceived Stress Scale (PSS; Cohen, Kamarck, \& Mermelstein, 1983), a 10-item questionnaire that asks users to rate on a scale of 0 (never) to 4 (very often) how frequently they experience various symptoms of feeling stress. Positive emotionality was measured using the emotion subscale of the Happify Scale (HS-E; Carpenter, Crutchley, Zilca, Schwartz, Smith, Cobb, \& Parks, 2016), which is a 4-item scale asking participants to rate the extent to which, over the past week, they have experienced positive and negative emotions that are activated or de-activated. Optimism was measured using the Life Orientation Scale, Revised (LOT-R; Scheier \& Carver, 1985), a 6-item scale on which participants rate the extent to which they identify with optimistic or pessimistic beliefs.

Depression Patient Health Questionnaire (PHQ-9; Kroenke, Spitzer, & Williams, 2001)From start of 8-week intervention (baseline) to immediately post-intervention

A 9-item measure of depressive symptoms

Generalized Anxiety Disorder Screener (GAD-7; Spitzer, Kroenke, Williams, & Löwe, 2006)From start of 8-week intervention (baseline) to immediately post-intervention

A 7-item measure of anxiety symptoms

Perceived Stress Scale (PSS: Cohen, Kamarck, & Mermelstein, 1983)From start of 8-week intervention (baseline) to immediately post-intervention

10-item measure of perceived stress

Trial Locations

Locations (1)

Happify (an online platform -- study is entirely online)

🇺🇸

New York, New York, United States

Happify (an online platform -- study is entirely online)
🇺🇸New York, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.